Trial Profile
Treatment of Edoxaban Versus Aspirin for Non-disabling Cerebrovascular Events: Rationale, Objectives, and Design
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Aspirin
- Indications Stroke
- Focus Therapeutic Use
- Acronyms Xijing-Edoxaban
- 22 Aug 2014 New trial record